NPF Legal Advisory Chair Talks Misleading Ads with FTC
On behalf of the Truth in Advertising Campaign, Marc Ullman presented FTC with 26 non-compliant marketers of dietary supplements.
Marc Ullman, legal advisory council chairman for the Natural Products Foundation (NPF; Washington, DC), met with the FTC’s Richard Cleland last week to discuss illegal drug claims on dietary supplements.
On behalf of NPF’s Truth in Advertising campaign-a team of volunteer attorneys who vet dietary supplements for illegal and misleading advertising-Ullman presented Cleland with documentation on 26 marketers currently making drug claims for dietary supplements. Unlike a number of companies approached by the Truth in Advertising program in years past, these 26 marketers failed to respond to NPF “warning letters” by bringing their marketing materials into legal compliance.
“With guidance, advertisers often correct their materials and move on without issue,” says Ullman. “Most are grateful for the educational resources and advice NPF provides, and quick to make their promotions right…however, when companies are unwilling or unable to bring advertising into compliance after they’ve been notified of a problem, then the only option left is regulatory action.”
Since 2010, the Truth in Advertising campaign has sent over 235 warning letters to dietary supplement companies and referred 73 cases to the FTC and FDA. Its team of volunteer attorneys includes Marc Ullman (Ullman, Shapiro, & Ullman; New York City), Jackie Kuler (Gronek & Associates; Chicago), Nicholas Licato (Nexgen Pharma; Irvine, CA), and Jim Prochnow and Justin Prochnow (Greenberg Traurig; Denver).
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
